During a live event, Tony Philip, MD, and participants discussed molecular profiling and active surveillance for desmoid ...

Desmoid tumor cells do not travel through the body like cancer, and most desmoids do not impact lifespan. But they can grow into nearby tissue and affect how the body functions at the site of the ...

Instead of surgery, experts and guidelines now recommend systemic therapies as first-line intervention for most desmoid tumors requiring treatment. In March 2023, Brooke—then 40 years old ...

Desmoid tumors are usually considered benign (not cancer) because they rarely spread to different parts of your body. But ones that grow fast (aggressive tumors) can be like cancer in some ways.

Desmoid tumors are difficult to treat when not amenable to resection. Two cases are reported in which there was regression of desmoid tumors in response to treatment with sorafenib and celecoxib.

Gain insights into valuable educational resources for patients coping with desmoid tumors, such as global consensus papers and advocacy group websites, and the significance of seeking multiple ...

Haumschild delves into the management of fatigue, insomnia, and financial difficulties in patients with desmoid tumors with Ratan. Ratan emphasizes the psychosocial toll on patients, ...

Brooke's mother also had 28 surgeries related to her desmoid tumors and multiple rounds of radiation and chemotherapy, which were the only treatment options available for her at the time.

Desmoid Tumor Advocacy Group Helped Make Nirogacestat a Success. Nirogacestat has an interesting history. It was originally developed to treat Alzheimer’s disease, but ultimately was not effective.

Desmoid tumors are a type of rare and challenging medical condition with an incidence of approximately 3-5 cases per million individuals. Despite being non-metastatic, these soft-tissue tumors exhibit ...

This interesting report describes a rare case of desmoid tumor in the PCL of the knee. News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point  Specialty: ...

SpringWorks Therapeutics drug Ogsiveo is now FDA-approved for treating desmoid tumors, a type of tumor affecting connective tissue. The regulatory decision makes the pill the first therapy ...